Tottenham Acquisition I set a Dec. 30 shareholder vote on its proposed merger with Clene Nanmedicine, a deal vlaued at $542.5 million. The preliminary proxy outlines terms of the deal and includes historical financial data on the merger target. Read more.
Tottenham Schedules Shareholder Vote on Clene Nanomedicine Merger
